Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

ClinicalTrials.gov ID: NCT03436199

Public ClinicalTrials.gov record NCT03436199. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 3-arm, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients With Walking Impairment

Study identification

NCT ID
NCT03436199
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Adamas Pharmaceuticals, Inc.
Industry
Enrollment
558 participants

Conditions and interventions

Interventions

  • ADS-5102, 137 mg Drug
  • ADS-5102, 274 mg Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 28, 2018
Primary completion
Dec 9, 2019
Completion
Dec 9, 2019
Last update posted
Dec 20, 2021

2018 – 2019

United States locations

U.S. sites
78
U.S. states
32
U.S. cities
76
Facility City State ZIP Site status
Adamas Clinical Site Cullman Alabama 35058
Adamas Clinical Site Phoenix Arizona 85032
Adamas Clinical Site Scottsdale Arizona 85251
Adamas Clinical Site Tucson Arizona 85704
Adamas Clinical Site Carlsbad California 92011
Adamas Clinical Site Fresno California 93710
Adamas Clinical Site Fullerton California 92835
Adamas Clinical Site Long Beach California 90806
Adamas Clinical Site Newport Beach California 92663
Adamas Clinical Site Sacramento California 95817
Adamas Clinical Site Aurora Colorado 80045
Adamas Clinical Site Colorado Springs Colorado 80907
Adamas Clinical Site Denver Colorado 80209
Adamas Clinical Site Fort Collins Colorado 80528
Adamas Clinical Site Fairfield Connecticut 06824
Adamas Clinical Site New London Connecticut 06320
Adamas Clinical Site Washington D.C. District of Columbia 20007
Adamas Clinical Site Maitland Florida 32751
Adamas Clinical Site Miami Florida 33136
Adamas Clinical Site Naples Florida 34105
Adamas Clinical Site Orlando Florida 32806
Adamas Clinical Site Ormond Beach Florida 32174
Adamas Clinical Site Palm Coast Florida 32164
Adamas Clinical Site Port Charlotte Florida 33952
Adamas Clinical Site Sarasota Florida 34233
Adamas Clinical Site Tampa Florida 33609
Adamas Clinical Site Vero Beach Florida 32960
Adamas Clinical Site Atlanta Georgia 30309
Adamas Clinical Site Savannah Georgia 31406
Adamas Clinical Site Northbrook Illinois 60062
Adamas Clinical Site Indianapolis Indiana 46256
Adamas Clinical Site Kansas City Kansas 66160
Adamas Clinical Site Lenexa Kansas 66214
Adamas Clinical Site Overland Park Kansas 66212
Adamas Clinical Site Foxborough Massachusetts 02035
Adamas Clinical Site Lexington Massachusetts 02421
Admas Clinical Site Detroit Michigan 48201
Adamas Clinical Site Farmington Hills Michigan 48334
Adamas Clinical Site Golden Valley Minnesota 55422
Adamas Clinical Site Kansas City Missouri 64111
Adamas Clinical Site St Louis Missouri 63110
Adamas Clinical Site Great Falls Montana 59405
Adamas Clinical Site Lincoln Nebraska 68506
Adamas Clinical Site Omaha Nebraska 68198
Adamas Clinical Site Las Vegas Nevada 89016
Adamas Clinical Site Albuquerque New Mexico 87131
Adamas Clinical Site Amherst New York 14226
Adamas Clinical Site Lake Success New York 11042
Adamas Clinical Site New York New York 10029
Adamas Clinical Site Patchogue New York 11772
Adamas Clinical Site Plainview New York 11803
Adamas Clinical Site Rochester New York 14642
Adamas Clinical Site Staten Island New York 10306
Adamas Clinical Site Charlotte North Carolina 28207
Adamas Clinical Site Raleigh North Carolina 27607
Adamas Clinical Site Centerville Ohio 45459
Adamas Clinical Site Cleveland Ohio 44195
Adamas Clinical Site Columbus Ohio 43214
Adamas Clinical Site Oklahoma City Oklahoma 73104
Adamas Clinical Site Portland Oregon 97225
Adamas Clinical Site Philadelphia Pennsylvania 19140
Adamas Clinical Site Charleston South Carolina 29406
Adamas Clinical Site Greer South Carolina 29650
Adamas Clinical Site Old Point Station South Carolina 29707
Adamas Clinical Site Spartanburg South Carolina 29307
Adamas Clinical Site Cordova Tennessee 38018
Adamas Clinical Site Franklin Tennessee 37064
Adamas Clinical Site Johnson City Tennessee 37604
Adamas Clinical Site Houston Texas 77030
Adamas Clinical Site Houston Texas 77074
Adamas Clinical Site Round Rock Texas 78681
Adamas Clinical Site Salt Lake City Utah 84103
Adamas Clinical Site Newport News Virginia 23601
Adamas Clinical Site Norfolk Virginia 23502
Adamas Clinical Site Kirkland Washington 98034
Adamas Clinical Site Seattle Washington 98101
Adamas Clinical Site Seattle Washington 98122
Adamas Clinical Site Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03436199, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2021 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03436199 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →